Edgewise Therapeutics CMO Joanne M. Donovan reports sale of 854 common shares for $38,839.92
EWTX•Edgewise Therapeutics CMO Joanne M. Donovan sold 854 shares at $45.48 each on Nov. 16, 2026, and directly owned 8,139 shares afterward.
1. Share sale
Joanne M. Donovan, chief medical officer of Edgewise Therapeutics, sold 854 common shares at $45.48 each on Nov. 16, 2026. She directly owned 8,139 shares following the transaction.




